텔레뉴로로지 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 서비스별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Teleneurology Market Summary

The global teleneurology market size was estimated at USD 6.12 billion in 2024 and is projected to reach USD 16.73 billion by 2033, growing at a CAGR of 11.62% from 2025 to 2033. Rising prevalence of neurological disorders, increasing adoption of telemedicine, advancements in technology,

Shortage of neurologists, and the cost-effectiveness and convenience of teleneurology are some factors driving the market. For instance, in April 2023, Eagle Telemedicine expanded its suite of telemedicine specialties by introducing Pediatric TeleNeurology to provide care for children with neurobehavioral disorders. Several developed countries and emerging economies need more trained medical professionals. The U.S. healthcare industry faces a severe workforce shortage, amplified by the challenges posed by the COVID-19 pandemic. Projections from Caliber Healthcare Solutions reveal a shortfall of up to 18,000 Neurologist physicians in 2024. Teleurology helps doctors reach more patients. It enhances access to healthcare, improves time management for patients & doctors, and helps reduce healthcare costs. People living in remote areas must travel for hours to access treatment; however, remote rural areas meet healthcare needs through teleurology services.

Moreover, Governments and healthcare organizations have expanded telehealth regulations, reimbursement policies, and digital infrastructure, making teleneurology a viable option for ongoing patient care. The normalization of remote consultations has become a key factor in market growth.

Technological innovations are driving the evolution of the teleneurology industry. High-resolution video conferencing tools, cloud-based electronic health records (EHRs), remote monitoring devices, and artificial intelligence (AI) for diagnostics have made virtual neurological assessments more reliable and accurate. For instance, in November 2023, the National Park Medical Center (NPMC) partnered with Access TeleCare to offer teleneurology services. This partnership allows onsite nurses, healthcare providers, and physicians to access top-tier teleneurology consultations, enabling them to respond promptly to stroke patients. In addition, they are equipped to treat individuals with conditions such as epilepsy, severe headaches, multiple sclerosis, and other neurological disorders.

Innovations such as AI-powered triage systems and advanced remote monitoring devices are helping healthcare providers deliver more accurate and timely care. The market is projected to continue growing, with telemedicine becoming an integral part of emergency care and overall healthcare delivery, offering benefits such as reduced wait times, enhanced access to care, and more efficient resource use.

• On-demand virtual urgent care: This model enables patients to consult remotely with a provider for low-acuity concerns, potentially replacing visits to urgent care or emergency departments. Scaling this model could virtually manage a larger share of minor emergencies and urgent visits.
• Virtual office visits with established providers: These visits, which include primary care and certain specialties (such as stroke epilepsy), through an omnichannel care model, enhance patient access, continuity, and convenience, particularly for chronic condition management supported by remote monitoring and digital tools.

Global Teleneurology Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global teleneurology market report based on application, service, end use, and region:

• Application Outlook (Revenue USD Million, 2021 - 2033)
• Stroke
• Parkinson
• Epilipesy
• Headache
• Multiple sclerosis
• Dementia
• Others
• Service Outlook (Revenue USD Million, 2021 - 2033)
• Tele-Consulting
• Tele-Monitoring
• Tele-Education
• End Use Outlook (Revenue USD Million, 2021 - 2033)
• Patients
• Providers
• Payers
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Application outlook
  • 2.2.2. Services outlook
  • 2.2.3. End Use outlook
• 2.3. Competitive Insights

Chapter 3. Global Teleneurology Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Global Teleneurology: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Technology Landscape
• 3.5. Case Study Analysis

Chapter 4. Global Teleneurology Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Application Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Teleneurology Market, by Application, 2021 to 2033
• 4.5. Stroke
  • 4.5.1. Stroke market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Parkinson
  • 4.6.1. Parkinson market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.7. Epilipesy
  • 4.7.1. Epilipesy market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.8. Headache
  • 4.8.1. Headache market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.9. Multiple sclerosis
  • 4.9.1. Multiple sclerosis market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.10. Dementia
  • 4.10.1. Dementia market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.11. Others
  • 4.11.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Global Teleneurology Market Segment Analysis, By Service, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Service Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Teleneurology Market, by Service, 2021 to 2033
• 5.5. Tele-Consulting
  • 5.5.1. Tele-Consulting market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Tele-Monitoring
  • 5.6.1. Tele-Monitoring market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Tele-Education
  • 5.7.1. Tele-Education market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Global Teleneurology Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. End Use Market Share Analysis, 2024 & 2033
• 6.3. Segment Dashboard
• 6.4. Global Teleneurology Market, by End Use, 2021 to 2033
• 6.5. Patients
  • 6.5.1. Patients market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.6. Providers
  • 6.6.1. Providers market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.7. Payers
  • 6.7.1. Payers market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Teleneurology Market Segment Analysis, By Region, 2021- 2033 (USD Million)

• 7.1. Regional Market Share Analysis, 2024 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Teleneurology Market Share by Region, 2024 & 2033:
• 7.5. North America
  • 7.5.1. North America teleneurology market, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Scenario
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. U.S. teleneurology market, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Scenario
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Canada teleneurology market, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Scenario
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Mexico teleneurology market, 2021 - 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe teleneurology market, 2021 - 2033 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Scenario
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. UK teleneurology market, 2021 - 2033 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Scenario
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Germany teleneurology market, 2021 - 2033 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Scenario
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. France teleneurology market, 2021 - 2033 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Scenario
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Italy teleneurology market, 2021 - 2033 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Scenario
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Spain teleneurology market, 2021 - 2033 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Scenario
    • 7.6.7.3. Competitive Scenario
    • 7.6.7.4. Norway teleneurology market, 2021 - 2033 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Regulatory Scenario
    • 7.6.8.3. Competitive Scenario
    • 7.6.8.4. Sweden teleneurology market, 2021 - 2033 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Regulatory Scenario
    • 7.6.9.3. Competitive Scenario
    • 7.6.9.4. Denmark teleneurology market, 2021 - 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Regulatory Scenario
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Japan teleneurology market, 2021 - 2033 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Scenario
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. China teleneurology market, 2021 - 2033 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Scenario
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. India teleneurology market, 2021 - 2033 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Regulatory Scenario
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Australia teleneurology market, 2021 - 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Regulatory Scenario
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. South Korea teleneurology market, 2021 - 2033 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Regulatory Scenario
    • 7.7.6.3. Competitive Scenario
    • 7.7.6.4. Thailand teleneurology market, 2021 - 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Regulatory Scenario
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. Brazil teleneurology market, 2021 - 2033 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Scenario
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. Argentina teleneurology market, 2021 - 2033 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key Country Dynamics
    • 7.9.1.2. Regulatory Scenario
    • 7.9.1.3. Competitive Scenario
    • 7.9.1.4. South Africa teleneurology market, 2021 - 2033 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Regulatory Scenario
    • 7.9.2.3. Competitive Scenario
    • 7.9.2.4. Saudi Arabia teleneurology market, 2021 - 2033 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Regulatory Scenario
    • 7.9.3.3. Competitive Scenario
    • 7.9.3.4. UAE teleneurology market, 2021 - 2033 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Regulatory Scenario
    • 7.9.4.3. Competitive Scenario
    • 7.9.4.4. Kuwait teleneurology market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Profiles
  • 8.3.1. Providence
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Lakewood Health System
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Eagle Telemedicine
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Medical University of South Carolina
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Blue Sky Telehealth
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Teladoc Health, Inc.
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. The Australian Stroke Alliance
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. American Well
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Sevaro Health, Inc.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Access TeleCare, LLC
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives